Skip to content

Predicting Exacerbation of COPD With Wireless Telemonitoring

Open-Label Prospective Study of Predicting Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) With Wireless Telemonitoring of Respiratory Rate, Heart Rate and Sleep

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02791451
Enrollment
6
Registered
2016-06-06
Start date
2016-10-31
Completion date
2017-12-31
Last updated
2021-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, telemonitoring, exacerbation

Brief summary

This is an open-label single-center 6-month prospective clinical trial predicting exacerbation of COPD with wireless telemonitoring of respiratory rate, heart rate and sleep in patients admitted to the pulmonary ward of the Turku University Hospital due to acute exacerbation of COPD.

Detailed description

A bed sensor based on ballistocardiogram (BCG) will be used to wireless telemonitoring of respiratory rate, heart rate and sleep for six months after an acute exacerbation of COPD.

Interventions

DEVICEtelemonitoring

To predict exacerbation of COPD with wireless telemonitoring

Sponsors

University of Turku
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive patients treated due to acute exacerbation of COPD at the pulmonary wards of the Turku University Hospital

Exclusion criteria

* Those sleeping with a bed partner and not having separate mattresses * Patients with pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Time window to detect acute exacerbation of COPDSix monthsTime window to detect acute exacerbation of COPD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026